126 related articles for article (PubMed ID: 35567630)
1. Effect of intra-nasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVID-19 patients.
Abdelazim MH; Abdelazim AH; Ismaiel WF; Alsobky ME; Younes A; Hadeya AM; Ramzy S; Shahin M
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4623-4628. PubMed ID: 35567630
[TBL] [Abstract][Full Text] [Related]
2. Effect of intra-nasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVD-19 patients.
Abdelazim AH
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4651. PubMed ID: 35809092
[No Abstract] [Full Text] [Related]
3. The Efficacy of Sodium Phytate as a Natural Chelating Agent in Reducing Elevated Calcium Levels in Nasal Mucus Among Individuals Experiencing Olfactory Dysfunction Following COVID-19: A Prospective Randomized Double-Controlled Clinical Trial.
Altemani AH; Alanazi MA; Altemani AH; Alharbi A; Alsahali S; Alotaib NM; Abdelazim MH
Am J Rhinol Allergy; 2024 Mar; 38(2):116-122. PubMed ID: 38105576
[TBL] [Abstract][Full Text] [Related]
4. Effect of Sodium Gluconate on Decreasing Elevated Nasal Calcium and Improving Olfactory Function Post COVID-19 Infection.
Abdelazim MH; Abdelazim AH
Am J Rhinol Allergy; 2022 Nov; 36(6):841-848. PubMed ID: 35942688
[TBL] [Abstract][Full Text] [Related]
5. Effect of intranasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVID-19 patients.
İslamoglu Y
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4649. PubMed ID: 35691978
[No Abstract] [Full Text] [Related]
6. Intra Nasal Use of Ethylene Diamine Tetra Acetic Acid for Improving Olfactory Dysfunction Post COVID-19.
Abdelazim MH; Mandour Z; Abdelazim AH; Ismaiel WF; Gamal M; Abourehab MAS; Alghamdi S; Alghamdi MA; Alrugi RR; Alharthi RR
Am J Rhinol Allergy; 2023 Nov; 37(6):630-637. PubMed ID: 37786364
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of pentasodium diethylenetriamine pentaacetate in ameliorating anosmia post COVID-19.
Imam MS; Abdelazim MH; Abdelazim AH; Ismaiel WF; Gamal M; Abourehab MAS; Alghamdi S; Alghamdi MA; Ghoneim MM; Elwany S
Am J Otolaryngol; 2023; 44(4):103871. PubMed ID: 37018923
[TBL] [Abstract][Full Text] [Related]
8. Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
Hosseinpoor M; Kabiri M; Rajati Haghi M; Ghadam Soltani T; Rezaei A; Faghfouri A; Poustchian Gholkhatmi Z; Bakhshaee M
Laryngoscope; 2022 Nov; 132(11):2209-2216. PubMed ID: 36054369
[TBL] [Abstract][Full Text] [Related]
9. The effect of intra-nasal tetra sodium pyrophosphate on decreasing elevated nasal calcium and improving olfactory function post COVID-19: a randomized controlled trial.
Abdelazim MH; Abdelazim AH; Moneir W
Allergy Asthma Clin Immunol; 2022 Aug; 18(1):67. PubMed ID: 35927706
[TBL] [Abstract][Full Text] [Related]
10. Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients.
Whitcroft KL; Gunder N; Cuevas M; Andrews P; Menzel S; Haehner A; Hummel T
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):2891-2897. PubMed ID: 33471169
[TBL] [Abstract][Full Text] [Related]
11. What about using sniffin' sticks 12 items test to screen post-COVID-19 olfactory disorders?
Vandersteen C; Payne M; Dumas LÉ; Plonka A; D'Andréa G; Chirio D; Demonchy É; Risso K; Robert P; Fernandez X; Askenazy-Gittard F; Savoldelli C; Guevara N; Castillo L; Manera V; Gros A
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3477-3484. PubMed ID: 34716806
[TBL] [Abstract][Full Text] [Related]
12. Clinical, Prognostic, and Predictive Value of Olfactory Dysfunction for COVID-19: A Prospective Controlled Study.
Kavaz E; Tahir E; Kurnaz SÇ; Deveci A; Tanyel EA
Otolaryngol Head Neck Surg; 2022 Jul; 167(1):187-196. PubMed ID: 34726987
[TBL] [Abstract][Full Text] [Related]
13. The effect of intranasal sodium citrate on olfaction in post-infectious loss: results from a prospective, placebo-controlled trial in 49 patients.
Whitcroft KL; Ezzat M; Cuevas M; Andrews P; Hummel T
Clin Otolaryngol; 2017 Jun; 42(3):557-563. PubMed ID: 27860366
[TBL] [Abstract][Full Text] [Related]
14. Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.
Di Stadio A; Gallina S; Cocuzza S; De Luca P; Ingrassia A; Oliva S; Sireci F; Camaioni A; Ferreli F; Mercante G; Gaino F; Pace GM; La Mantia I; Brenner MJ
Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4949-4961. PubMed ID: 37380908
[TBL] [Abstract][Full Text] [Related]
15. [Clinical application of Sniffin' Sticks olfactory psychophysical measurements].
Yang L; Wei YX; Ren YY; Yu D; Sun YX; Yang BB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Sep; 48(9):741-5. PubMed ID: 24330876
[TBL] [Abstract][Full Text] [Related]
16. Olfaction and quality of life in patients with nasal septal deviation treated with septoplasty.
Valsamidis K; Printza A; Titelis K; Constantinidis J; Triaridis S
Am J Otolaryngol; 2019; 40(5):747-754. PubMed ID: 31345588
[TBL] [Abstract][Full Text] [Related]
17. Olfactory dysfunction in patients after recovering from COVID-19.
Otte MS; Eckel HNC; Poluschkin L; Klussmann JP; Luers JC
Acta Otolaryngol; 2020 Dec; 140(12):1032-1035. PubMed ID: 32852240
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
D'Ascanio L; Vitelli F; Cingolani C; Maranzano M; Brenner MJ; Di Stadio A
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4156-4162. PubMed ID: 34156697
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Olfactory Cleft Width and Volumes in Patients with COVID-19 Anosmia and COVID-19 Cases Without Anosmia.
Tekcan Sanli DE; Altundag A; Yıldırım D; Kandemirli SG; Sanli AN
ORL J Otorhinolaryngol Relat Spec; 2022; 84(1):1-9. PubMed ID: 34569549
[TBL] [Abstract][Full Text] [Related]
20. Long-Lasting Olfactory Dysfunction in Hospital Workers Due to COVID-19: Prevalence, Clinical Characteristics, and Most Affected Odorants.
Delgado-Losada ML; Bouhaben J; Ruiz-Huerta C; Canto MV; Delgado-Lima AH
Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
